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Abstract
Objective—SMAD proteins are downstream effectors of the TGF-β signaling pathway. Smad3
null mice develop colorectal cancer by 6 months of age. In this study, we have examined whether
the loss of Smad3 promotes gastric neoplasia in mice.
Design—The stomachs of Smad3−/− mice were compared with age-matched Smad3
heterozygous and wild type mice. E-cadherin, Ki-67, phosphoSTAT3, and TFF2/SP expression
was analyzed by immunohistochemisty. The shRNA-mediated knockdown of Smad3 in AGS and
MKN28 cells was also performed. In addition, we examined alterations in DCLK1-expressing
cells.
Results—Smad3−/− mouse stomachs at 6 months of age revealed the presence of exophytic
growths along the lesser curvature in the proximal fundus. Six-month-old Smad3−− mouse
stomachs showed metaplastic columnar glands initiating from the transition zone junction between
the forestomach and the glandular epithelium along the lesser curvature. Ten month-old Smad3−/−
mice all exhibited invasive gastric neoplastic changes with increased Ki-67, phosphoSTAT3
expression, and aberrant cytosolic E-cadherin staining in papillary glands within the invading
submucosal gland. The shRNA-mediated knockdown of Smad3 in AGS and MKN28 cells
promoted the expression of phosphoSTAT3. DCLK1-expressing cells, which also stained for the
tuft cell marker acetylated-α-tubulin, were observed in 10-month-old Smad3−/− mice within
tumors and in fundic invasive lesions.
Conclusion—Smad3 null mice develop gastric tumors in the fundus, which arise from the
junction between the forestomach and the glandular epithelium and progress to prominent invasive
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tumors over time. Smad3 null mice represent a novel model of fundic gastric tumor initiated from
forestomach/glandular transition zone along the lesser curvature.
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INTRODUCTION
Gastric cancer remains the fourth most commonly diagnosed cancer globally and the second
most common cause of cancer mortality, worldwide.(1) The most common types of gastric
cancer are adenocarcinomas. Gastric adenocarcinomas develop throughout the stomach and
are often defined by regional location as proximal, fundic, incisural or distal (antral). Over
the past 30 years, in western countries, there has been a shift towards an increase in the
frequency of gastric cancers arising in the proximal stomach compared to the antrum.(2)
Functionally, the human gastric mucosa is divided into the oxyntic gland area and the
pyloric gland area. The proximal 80% of the stomach, including the mucosa of the body and
fundus, is occupied with the oxyntic area, which secretes acid and pepsinogen. Gastric
adenocarcinomas of the intestinal type are believed to develop through a process of multiple
stages that include chronic gastritis, oxyntic atrophy, foveolar hyperplasia and metaplasia.
(3)
Smads are recognized as downstream intracellular proteins in the signaling of transforming
growth factor β (TGF-β), which is mediated through a heteromeric complex of two types of
transmembrane receptors: TGF-β recepter type I and II.(4) Ligands in this family include
three mammalian TGF-βs, activins, and bone morphogenetic proteins (BMPs). Pathway-
specific Smads consist of Smads 1, 5, and 8 that mediate BMP signaling and Smads 2 and 3
that mediate TGF-β and activin signaling.(5) Activated Smad2 and Smad3 form a
heteromeric complex in the cytoplasm with the common mediator, Smad4, and this complex
translocates into the nucleus to activate transcription of various target genes.(6) Every
component of the TGF-β signaling pathway can be altered in cancer including TGF-β
receptors, Smads, and Smad target genes. Defects in the targets of the TGF-β signal
transduction pathway are observed in many gastrointestinal tumors.(7, 8) The loss of
expression of TGF-β receptor type II in association with resistance to the growth inhibitory
effect of TGF-β has been reported in both gastric (9) and colon cancer.(10)
In human gastric cancer, no mutations in the Smad2 gene have been reported,(11) but loss of
Smad4 was frequently found in gastric cancer. In the setting of gastric carcinogenesis, loss
of Smad4 expression is frequently observed and correlated with poor clinical outcome.(12–
14) Consistent with this, the haploid loss of Smad4 initiates gastric carcinogenesis in mice.
(15) In addition, reduced Smad4 expression is observed more frequently in diffuse-type than
in intestinal-type gastric carcinomas.(13) Although Smads 4 and 2 have tumor suppressor
activities, Smad3 may also contribute to the oncogenic activities of TGF-β.(16) It remains
controversial whether Smad3 functions as a tumor suppressor. However, a recent study
showed that expression of Smad3 was suppressed in a subset of human gastric cancers and
human gastric cell lines, most likely due to aberrant expression of Smad3 inhibitors.(7)
Smad3-deficient mice have been generated in different laboratories with different strategies.
In colon cancer, these mice have a variable phenotype depending on the genetic background
and/or on environmental factors associated with animal husbandry.(17) One group has
shown 100% penetrance of invasive colon carcinoma (18), while other groups have shown
no malignancies.(19, 20)
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Although the genes encoding TGF-β recepters and Smads are genetically altered in certain
human cancers, until now no report has considered the role of Smad3 in the early stages of
gastric carcinogenesis in mice. We have now examined whether the loss of Smad3 promotes
gastric cancer in mice. In this study, we found that Smad3 null mice develop progressive and
invasive gastric tumors that arise from the junction between forestomach and glandular
epithelium along the lesser curvature. These lesions exhibit the expansion of doublecortin
and Ca2+/calmodulin-dependent kinase-like-1 (DCLK1)-expressing tuft cells throughout
tumors in the proximal stomach. These findings suggest that Smad3 null mice represent a
novel model of fundic gastric tumorigenesis.
MATERIALS AND METHODS
Mice
The Smad3+/− mice were mated with heterozygous partners to obtain knockout and wild-
type littermate control mice for these studies. Mice were maintained on the B6;129/S
background under specific pathogen-free conditions in individual, sterile microisolator cages
in non-barrier mouse rooms. B6;129/S mice were obtained from Jackson Laboratories (Bar
Harbor, ME). During the experiments, the mice were maintained with regular mouse chow
and water ad libitum in a temperature-controlled room under a 12-h light/dark cycle. The
care, maintenance, and treatment of animals in these studies followed protocols approved by
the Institutional Animal Care and Use Committee of Vanderbilt University.
Histopathological Examination
Immediately after sacrifice, mouse stomachs were opened along the greater curvature. The
excised stomachs were fixed in 4% paraformaldehyde and cut into approximately 6 strips,
processed by standard methods, embedded in paraffin, sectioned at 5 μm, and stained with
hematoxylin and eosin.
Immunohistochemistry
We carried out immunohistochemistry according to manufacturer’s recommendations,
typically using a modified citric acid unmasking protocol followed by standard detection
with 3,3-diaminobenzidine (DAB) or alkaline phosphatase using a kit from Vector
Laboratories. Samples were counter-stained with hematoxylin. In some cases, secondary
antibodies were conjugated to AlexaFluor 488 (Invitrogen, Camarillo, CA) or Cy-3 and
nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI). We used the
following primary antibodies: mouse IgM anti-TFF2/SP(1: 250, Abcam, Cambridge, MA),
rabbit IgG anti-HE4 (1:1000, Abcam), mouse IgG anti-E-cahderin (1:800, BD Transduction,
San Diego, CA), rabbit IgG anti-phosphoSTAT1, rabbit IgG anti-phosphoSTAT3 (1:50, Cell
signaling, Danvers, MA), rabbit IgG anti-phosphoSTAT6 (1:1000, Abcam, Cambridge,
MA), rat IgG anti- Ki-67 (1:50, Dako, Carpinteria, CA), rabbit IgG anti-DCLK1 (1:500,
Abgent, San Diego, CA), mouse IgG anti- Chromogranin A (1:25, AbD Serotec, Raleigh,
NC), rabbit IgG anti-α-gustducin (1:5000, Santa Cruz, Santa Cruz, CA), mouse IgG anti-
Acetylated-α-tubulin (1:10000, Sigma, St. Louis, MO). The number of DCLK1-positive
cells was analyzed in all strips of each stomach. Using an Ariol SL-50 slide scanner imaging
system (Genetix, San Jose, CA; Vanderbilt Epithelial Biology Center Shared Resource) and
light microscopy (200 X), we examined 6 month old Smad3−/− mice (mucosal length of
37,200 μm), 10 month Smad3−/− mice (mucosal length of 43,400 μm) and wild type mice
(mucosal length of 62,000 μm) to determine positive cells in the oxyntic mucosa.
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Cell culture
The human gastric cancer cell lines AGS and MKN28 (American Type Culture Collection,
ATCC, Manassas, VA) were maintained in DMEM media supplemented with 10% fetal
bovine serum at 5% CO2.
Smad3 stable Knockdown cells using lentiviral short hairpin RNA
Five premade lentiviral Smad3 short hairpin RNA (shRNA) constructs and a negative
control construct that was created in the same vector system (pLKO.1) were purchased from
Open Biosystems (Huntsville, AL). Lentiviral helper plasmids (pCMV-dR8.2 dvpr and
pCMV-VSV-G) were obtained from Addgene (Cambridge, MA). Transient lentivirus stocks
were prepared following the manufacturer’s protocol in 293T cells. MKN28 and AGS cells
that were stably expressing shRNA constructs were selected with 0.5 to 2 μg/ml of
puromycin 48 h after lentivirus infection. After two weeks of selection, monolayers of stably
infected pooled clones were harvested for use and cryopreserved.
Western blotting
Proteins were transferred to a nitrocellulose membrane and blots were probed with the
primary antibodies: rabbit anti-Smad3 (Abcam); rabbit anti-phosphorylated STAT3
(phospho-Tyr705); rabbit anti-STAT3 (Cell Signaling); mouse anti-beta-actin (Abcam)
followed by incubation with horseradish-peroxidase conjugated secondary antibodies and
detection with Supersignal substrate (Pierce).
Statistics
The data were analyzed with the JMP software package (version 4.0; SAS Institute, Cary,
NC). DCLK1-positive cell numbers were compared by analysis of variance followed by post
hoc analysis of significant means by the Dunnett test. For all comparisons, P values less than
0.05 were considered statistically significant.
RESULT
Smad3−/− mice exhibit progressive gastric gland metaplasia and invasive gastric
neoplasia that arises from the forestomach/glandular junction along the lesser curvature
Although the genes encoding TGF-β receptors and Smads are genetically altered in certain
human cancers, until now, no report has considered the role of Smad3 in the early stages of
gastric carcinogenesis in mice. To examine the effects of Smad3 deficiency, we evaluated
the stomachs of Smad3−/− mice at 4, 6, and 10 months of age compared with age-matched
Smad3 heterozygous and wild type (WT) mice. None of the Smad3−/− mice on the B6;129/S
background showed any significant gross anatomical or pathological abnormalities in the
stomach at 4 months of age (data not shown). Examination of Smad3−/− mouse (n=6)
stomachs at 6 months of age revealed the presence of grossly whitish exophytic growths in
the limiting ridge along the lesser curvature in all of the mice, while stomachs from Smad3
heterozygote (n=7) and WT mice (n=5) exhibited normal gastric morphology (Figure 1A).
Histologically, all 6-month-old Smad3−/− mouse stomachs showed metaplastic columnar
glands initiated from the transition zone at the junction between the forestomach and the
glandular epithelium along the lesser curvature of the stomach (Figure 1B & C). However,
both the greater curvature of Smad3−/− mice and lesser curvature of Smad3+/− mice showed
a normal histological appearance in the transition zone junction between the squamous
forestomach and the glandular epithelium (Figure 1B and D). These initial metaplastic
changes in the gastric mucosa of Smad3 null mice were analyzed by immunohistochemistry
staining for TFF2/SP, which is a marker of SPEM (spasmolytic polypetide-expressing
metaplasia). In glands within the fundic mucosa adjacent to the forestomach, TFF2/SP-
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immunoreactive mucous cells were present in metaplastic glands that showed branching at
their bases (Figure 1E and F).
To investigate the progression of initial gastric gland metaplasia in the junction, a total of
seven 10 month-old Smad3−/− mice and five Smad3+/+ mice were examined histologically.
While the greater curvature of 10 month-old Smad3−/− mice showed normal gastric
morphology, the lesser curvature exhibited neoplastic progression showing metaplastic
fundic glands expanding out towards the antrum from the forestomach/glandular junction
(n=7) (Figure 2A). In glands within the fundic mucosa adjacent to the forestomach, some
areas of high-grade dysplasia arising under the junction were observed (Figure 2A Box and
B). The dysplastic cells showing prominent nuclear pleomorphism and disorganization
expanded from the junction into the fundic mucosa, where they replaced the normal foveolar
cells and fundic glands (Figure 2B). Interestingly, we observed the presence of numerous
cystic structures within the submucosa of the gastric wall (Figure 2A arrows, C and D). The
glands abnormally invading within the muscle of the gastric wall were lined by well-
differentiated metaplastic epithelial cells containing basal nuclei forming multiply extended
glandular formations (Figure 2D). The gastric mucosa of Smad3−/− mice exhibited areas of
metaplasia with prominent TFF2/SP expression, including in epithelial cells lining cysts
invading into the gastric wall (Figure 2E and F). We did not observe any other normal
differentiated gastric lineages in these areas, including surface mucous cells, parietal cells
and chief cells (data not shown). We also analyzed these metaplastic changes in TFF2/SP
positive-epithelial cells lining cysts invading into the gastric wall by immunostaining for
human epididymis 4 (HE4/WFDC2), which is not present in the normal stomach, but is
strongly expressed in SPEM. (21) We observed strong HE4 expression in the cysts invading
into the gastric wall (Figure 2G). These results support the concept that gastritis cystica
profunda is a manifestation of an ongoing metaplastic process in the Smad3 deficient mice.
Increased expression of oncogenic markers in the gastric mucosa of Smad3−/− mice
We next sought to examine whether oncogenic markers were expressed in gastric tumor
cells in Smad3−/− mice. To investigate the characteristics of the tumor in Smad3−/− mice, we
immunostained gastric tissue for markers associated with neoplastic transformation with
antibodies against Ki-67, E-cadherin and STATs. Ki-67 antigen is a cell cycle related
nuclear protein commonly used as a proliferation marker in proliferating and neoplastic
tissues, including the stomach. In cells throughout the metaplastic fundic glands, including
cystically dilated glands invading into submucosa as well as gastric epithelial glands within
the muscle layers of gastric wall, we detected proliferating cells by Ki-67 staining (Figure
3A and B). Nevertheless, some regions of gastric epithelial cells within cysts penetrating
through the muscle of the gastric wall showed no expression of Ki-67 (Figure 3C).
E-cadherin is a cell adhesion molecule that is essential to maintain the integrity of cell-cell
contact in epithelial cell layers, and aberrant expression of E-cadherin is associated with
gastric cancer histological subtypes.(22, 23) There is general agreement that the absence or
reduction of E-cadherin expression occurs more frequently in diffuse gastric cancer than in
the intestinal type cancers. Membrane-localized E-cadherin was detected in metaplastic
glands cells within the mucosa, but we observed numerous cells containing aberrant
cytosolic staining in papillary glands invading into the submucosa (Figure 3D).
Nevertheless, we did not observe any significant relocation of β-catenin from the junctions
to the cytosol or nucleus (data not shown).
Since inflammatory cells and their interactions with epithelial cells may be involved in
carcinogenesis, we examined STAT proteins as central regulators of immune responses in
the tumor microenvironment. Signaling by various STATs play an essential role in
inflammation and cancer. To investigate the activation of the STAT family in invasive
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tumor tissues of Smad3−/− mice, we examined whether STAT1, STAT3 and STAT6 were
phosphorylated and activated in epithelial cells in Smad3 null mice. The activated
phosphorylated form of STAT3, phosphoSTAT3, was observed in the gastric epithelial cells
just above invading glands within the muscle layer (Figure 3E), but staining for
phosphoSTAT1 and phosphoSTAT6 was not observed (data not shown). Nevertheless, no
phosphoSTAT3 staining was present in the invading tumor cells.
Depletion of Smad3 protein in AGS and MKN28 gastric cancer cells leads to increased
phosphorylated form of STAT3
Considering our findings that metaplastic cells in Smad3 null mice exhibited the activated
phosphorylated form of STAT3, phosphoSTAT3, we sought to determine whether loss of
Smad3 expression directly affects STAT3 activation. We used Smad3shRNA lentivirus and
puromycin to select for stable pools of AGS and MKN28 cells with Smad3 depletion along
with control lines with pLKO.1. When stable cell pools were analyzed for Smad3 protein
expression by immunoblot, we found that Smad3 protein expression was significantly
suppressed in the two cell lines selected with Smad3shRNA lentivirus, but not with the
control pLKO.1 virus (Figure 4 first lane). While Smad3 knockdown had no effect on
STAT3 expression in both AGS and MKN28 cell lines, phosphoSTAT3 was prominently
increased in Smad3 knockdown cell lines (Figure 4). These results indicate that loss of
Smad3 expression can lead directly to increased STAT3 phosphorylation.
DCLK1-positive cells are expanded in gastric tumors arising from the junction in
Smad3−/− mice
Tumorigenesis is thought to arise specifically from resident mucosal stem cell populations.
Recently, DCLK1 was identified as a putative quiescent intestinal stem cell marker in the
intestinal crypt.(24) Therefore, we investigated whether DCLK1-positive cells were also
expressed in stomach mucosa. In the normal fundus of wild type mice, a few DCLK1-
positive cells were located in the neck-isthmus region of the glandular unit, in the same area
where normal stem/progenitor cells reside (Figure 5A center). In the antrum, a few scattered
DCLK1-positive cells were located in middle of antral glands (Figure 5A right).
Interestingly, long spindle shaped DCLK1-positive cellswere present in the first fundic
gland at the transition between the forestomach and the glandular epithelium (Figure 5A
left). Due to the location of DCLK1-positive cells at the junction between the forestomach
and the glandular epithelium, we investigated whether the DCLK1-positive cells were
present at the sites of tumor initiation in the transition zone junction between the
forestomach and the glandular epithelium in Smad3−/− mice. We observed a prominent
expansion of DCLK1-positive cells in the junction between the forestomach and the
glandular epithelium in Smad3−/− mice (Figure 5B). In the middle of developed tumors,
DCLK1-positive cells represented a large component in metaplastic glands including in the
area of initiated invasion (Figure 5C). In invading epithelial glands within muscle wall,
DCLK1-positive cells were present throughout the cystic gland epithelium. The DCLK1-
labeled cells had projections to the gland lumen (Figure 5D). However, we did not observe
any increase in DCLK1-expressing cells in the antrum of 10 month-old Smad3−/− mice
(Figure 5E).
DCLK1-positive cells do not express biomarkers associated with other differentiated
lineages in Smad3−/−mice tumor
To investigate whether DCLK1-positive cells co-localized with SPEM, we conducted dual
immunostaining for DCLK1 and TFF2/SP in a tumor area including areas with invasion.
DCLK1-positive cells did not co-stain with TFF2/SP in any region of tumor including
invading epithelial glands within the muscle wall (Figure 6A and D). To determine whether
DCLK1-positive cells expressed with progenitor cell or enteroendocrine markers, we
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performed double-label immunofluorescence staining for DCLK1 with Ki-67 and
chromogranin A, respectively. There was no co-localization observed for any of the markers
tested (Figure 6B–C). These data suggest that DCLK1 marks a unique cell lineage within the
mouse stomach tumor.
DCLK1-positive cells in Smad3−/− mouse tumors arising from the junction between the
forestomach and the glandular epithelium are tuft cells
Recent studies have suggested that DCLK1 immunoreactivity represents a highly specific
and robust marker of post-mitotic, differentiated, tuft cells, a minority cell lineage of the
intestinal epithelium, rather than a marker for intestinal epithelial stem cells.(25, 26) Tuft
cells are part of the diffuse chemosensory system, found scattered in multiple epithelia
including the gastrointestinal tract.(27) Therefore we examined whether the markers of the
tuft cell identify the prominent DCLK1-positive cell lineage found in Smad3−/− mouse
tumors arising from the junction between the forestomach and the glandular epithelium. To
visualize the complex microtubule bundles present at the apical surface of tuft cells, we
performed double-label immunofluorescence staining for DCLK1 with acetylated-α-tubulin
in both normal stomach and tumor developed in Smad3−/− mice. In the normal stomach at
the junction between the forestomach and glandular epithelium, DCLK1-positive cells co-
localized with acetylated-α-tubulin in the apical region of cell. In tumors of Smad3−/− mice,
including invasive glandular lesions within the muscle wall, DCLK1-positive cells co-
localized with acetylated-α-tubulin in the apical region of cell. These double positive
microtubule-rich sensory cilia labeled with DCLK1 and acetylated-α-tubulin in the apical
regions of cells protruding into the lumen (Figure 7A and B).
Tuft cells of the mouse stomach express α-gustducin, a heterotrimeric GTP-binding protein
α-subunit that is implicated in sweet and bitter taste signal transduction(28), in cells
scattered throughout the fundic mucosa.(29, 30) In addition, previous investigations have
noted that a remarkably high number of α-gustducin-positive cells are clustered within the
first gland of the fundic mucosa underneath the tissue fold of the so-called “limiting ridge”.
(29) We therefore sought to determine whether the cells expressing DCLK1 also expressed
α-gustducin in Smad3−/− mice tumors initiated from the junction between the forestomach
and the glandular epithelium. We performed double-labeled immunofluorescence staining
for DCLK1 with α-gustducin in both normal stomach and tumor developed in Smad3−/−
mice. In wild type mice, in the first gland at the junction between the forestomach and
glandular epithelium, some of DCLK1-positive cells co-localized with α-gustducin. In the
tumors of Smad3−/− mice, only a few of the DCLK1-positive cells co-localized with α-
gustducin. These double positive cells were located within metaplastic glands and formed
extensions to the gland lumen. (Figure 7C). The vast majority of the DCLK1 cells did not
express α-gustducin. These results indicate that while the DCLK-1-expressing cells are tuft
cells, there may be subspecialization amongst these sensory cells in terms of the taste
receptors that they express.
DISCUSSION
The Smad3 null mouse model represents a unique model of gastric neoplasia arising in the
proximal fundic mucosa. Previous investigations have focused attention on models of gastric
neoplasia that localize either to the fundic mucosa in general or to the antrum. Mice infected
with either H. felis or H. pylori develop metaplastic and dysplastic changes in the acid-
secreting fundic mucosa.(31–34) Similarly, models of acute parietal cell loss elicit
metaplastic changes in the fundus.(35, 36). Similar results are also seen in H. pylori-infected
Mongolian gerbils.(37) In contrast, several genetic models including TFF1 null, gastrin null
and gp130 mutant mice develop gastric dysplasia and neoplasia confined to the antrum.(38–
40) The Smad3 null mouse model described in the present studies shows development of a
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distinctly proximal fundic dysplastic lesion that appears to arise from the first gland of the
fundic mucosa along the lesser curvature of the stomach at the junction between the
squamous forestomach and the glandular epithelium. These studies therefore reveal a
process of neoplasia that is uniquely referable to the proximal stomach.
Smad3 is an intracellular transducer of TGF-β signals. Functionally significant mutations in
Smad2 have been detected in some human sporadic colorectal cancers,(41) but were not
detected in gastric cancer.(11) Despite the close sequence similarity between Smad2 and
Smad3, mutations in the Smad3 gene have not been reported in human colorectal cancer.
(42) However, recent investigations have indicated that the expression of Smad3 was
suppressed in a subset of human gastric cancers and human gastric cell lines, most likely due
to aberrant expression of Smad3 inhibitors.(7) Moreover, the re-expression of Smad3 in
Smad3-deficient gastric cancer cells restored TGF-β signaling and induced a tumor
suppressive activity.(7) Smad2 and Smad3 differ in their effect on mouse tumorigenesis.
Homozygous Smad2-null mice are embryonic lethal, whereas heterozygous Smad2 mice
show no evidence of tumor development.(43, 44) However, homozygous Smad3-null mice
are viable and develop a low multiplicity of invasive colonic adenocarcinomas in the 129/Sv
background.(18) We have found that Smad3 null mice in the B6;129/S background develop
progressive and invasive gastric tumors initiated from the junction between forestomach and
glandular epithelium along the lesser curvature. No previous report has indicated the
presence of the gastric tumors in Smad3 null mice except in a notation on the Jackson
Laboratory (Bar Harbor, ME) website (http://jaxmice.jax.org/strain/003451.html). While the
gastric tumors develop in this strain at 4–6 months age at the Jackson Laboratory and in our
colony, colorectal adenocarcinomas were not observed at the Jackson Laboratory facility. To
develop the colon cancer in Smad3-deficient mice, Helicobacter hepaticus infection is
required.(45) While colon cancer phenotypes did not developed in Smad3 null mice on the
129/Sv background maintained in a Helicobacter-free environment for up to 9 months,
infection of the same mice with Helicobacter triggered colon cancer in 50% to 66% of the
mice.(45) These results suggested that the original Smad3 null mice might have been
infected with Helicobacter hepaticus or other colitis-inducing organisms.(18) In contrast, the
development of spontaneous and invasive gastric tumors in Smad3 deficient mice appears to
be independent of Helicobacter infection.
An important finding in our current study is that the gastric tumors in Smad3 null mice
developed at the junction between forestomach and glandular epithelium along the lesser
curvature. The first gland of the gastric fundus appears to have a unique compendium of
lineages. It is devoid of parietal cells and chief cells and contains mucous cells and
endocrine and sensory tuft cells. This first gland is present in most, if not all, mammalian
species either at the border of the forestomach and glandular fundus as in rodents or at the
esophagogastric junction as in humans and rabbits. Previous investigations have suggested
that this first glandular unit may have unique regenerative properties. Canfield et al (46)
reported that, while mice expressing HSV thymidine kinase in parietal cells (H/K-ATPase-
thymidine kinase mice) treated with ganciclovir sloughed their entire fundic mucosa, the
first gland was protected and re-epithelialization of the fundus was observed emanating from
cells migrating out of this first gland remnant.(46) These results suggested that the first
glandular unit was isolated from gap junctions responsible for spreading toxic ganciclovir
adducts through the fundic mucosal cells. Others have noted that the first glandular unit in
the mouse stomach is enriched for cells expressing either Lgr5(47) or DCLK1,(24) putative
markers of intestinal progenitor cells. Most recently, McKeon and colleagues have reported
that the first glands are a repository of residual embryonic cells in the adult mouse. (48) All
of these investigations indicate that the first gland of the fundus may represent a repository
for cells capable of rescuing severe mucosal damage in the stomach. Lee and
investigators(49) have emphasized that severe pathology more often develops in regions of
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the gastric epithelium where there is a marked transition in the census of acid-producing
parietal cells. The transitional zones are dynamic rather than static areas.(49) Thus, the
prominence of DCLK1-expressing cells in the invasive glands in 10-month old may reflect
the origin of the tumors from the cells of this first fundic gland.
Normally, cellular proliferation in the body and fundus of the stomach is restricted to the
progenitor zone in the gland isthmus.(50) Recently, doublecortin and Ca2+/calmodulin-
dependent kinase-like-1 (DCLK1), a microtubule-associated kinase expressed in postmitotic
neurons, has been suggested as a putative quiescent intestinal stem cell marker. Originally
this gene was identified as a potential stem cell marker from cDNA libraries prepared from
laser capture microdissected small intestinal and gastric epithelial progenitor populations.
DCLK1 expression was upregulated in an enriched gastric epithelial progenitor cell
population from the fundus.(51) DCLK1-expressing cells resided in the isthmus region of
the stomach glands and did not express biomarkers associated with differentiated lineages.
(24, 51) However, recent studies have indicated that DCLK1 is expressed in tuft cells.(25)
Tuft cells, also known as brush, caveolated, or multivesicular cells, are part of the diffuse
chemosensory system, found scattered in multiple epithelia including the gastrointestinal
tract.(27) Their most characteristic morphological features are long and blunt microvilli,
which have prominent rootlets and a well developed tubulovesicular system in the
supranuclear cytoplasm.(27) Despite the many morphological studies conducted to date, the
functions of tuft cells are still obscure. Immunohistochemical studies demonstrating the
presence of α-gustducin, the GTP-binding α-subunit of a trimeric G protein complex
implicated in taste signal transduction, have shed further light on the function of tuft cells.
(27, 52) Since α-gustducin was first described in taste receptor cells of the tongue,(53) and
was subsequently found in tuft cells of the alimentary tract, many investigators now consider
these cells as chemoreceptive in nature. Recently, Hass et al. (29) found a large cluster of α-
gustducin-positive cells located at junction between forestomach and fundic mucosa of the
mouse stomach, at the so-called “limiting ridge”. In our study, DCLK1-positive cells in
Smad3−/− mouse tumors initiated from the junction between the forestomach and the
glandular epithelium were immunoreactive for α-gustducin. While the number of DCLK1-
positive cells increased in Smad3−/− tumors, only a subset of these were immunoreactive for
α-gustducin. Nevertheless, the vast majority or all of the DCLK1 positive cells were also
immunoreactive for acetylated-α-tubulin staining of the complex microtubule bundle at the
apical surface. DCLK1/acetylated-α-tubulin dual positive cells were present in the epithelial
cells in the tumor and the invasive area developed in Smad3−/− mice. Importantly, we did
not observe any co-labeling of DCLK1 with either TFF2/SP or Ki-67. These results all
indicate that a DCLK1-expressing tuft cell lineages is markedly expanded during the
progression of invasive proximal gastric neoplasia in Smad3 deficient mice.
In summary, Smad3 null mice develop gastric tumors in the fundus, which arise at the
junction between the forestomach and the glandular epithelium. The tumors appear to
develop from the first glandular unit of the fundic mucosa and progress to prominent
invasive tumors. Progression to more invasive lesions is accompanied by an expansion of
tuft cells marked by DCLK1 expression. These findings suggest that Smad3 null mice
represent a novel model of fundic gastric tumor initiated from forestomach/glandular
transition zone along the lesser curvature.
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Figure 1. Initiation of gastric tumor in 6-month-old Smad3−/− mice
(A) Gross appearance of the stomach from a 6-month-old Smad3 deficient mouse. Note the
irregular whitish cauliflower-like growths in the limiting ridge along the lesser curvature.
Filled multiple arrows correspond to the locations of sections in (B). (B) H&E staining of
the stomach of a 6-month-old Smad3 deficient mouse. While the greater curvature of
Smad3−/− mice (KO) and lesser curvature of Smad3+/− (Het) mice showed normal
histological appearance in transition zone junction between the forestomach and the
glandular epithelium (B and D), in Smad3−/− mice (KO) mucosal metaplasia extended from
the lesser curvature in (B and C). C Higher magnification of the lesser curvature of
Smad3−/− mouse section in B (KO). D. Higher magnification of the greater curvature of
Smad3−/− mouse section in B (KO). E. TFF2/SP staining of metaplastic glands initiated
from the first fundic gland at the junction between the forestomach and the glandular
epithelium. F. Higher magnification of E. Bar size, 50μm
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Figure 2. Progression of gastric tumor and invasion in 10-month-old Smad3−/− mice
(A) H&E staining shows the lesser curvature with neoplastic progression and metaplastic
fundic glands expanding out towards the antrum from the forestomach/glandular junction.
Note the presence of numerous cystic structures within the submucosa of the gastric wall
(arrows). However, the greater curvature showed normal gastric morphology. Filled dark
brown arrow (left side) indicates the arrangement of sections from the lesser curvature to the
greater curvature. (B) Higher magnification of lesser curvature in A. The dysplastic cells
showing prominent nuclear pleomorphism and disorganization. (C) Higher magnification of
invasive glands in the muscle wall from panel A, second section. (D) Higher magnification
of invasive glands in muscle wall from panel A, fourth section. (E) TFF2/SP expression in
metaplastic glands and in epithelial cells lining cysts within the invasive region of the gastric
wall. (F) Higher magnification of E. (G) HE4 expression in TFF2/SP positive epithelial cells
lining cysts within the invasive region of the gastric wall. Bar size, 100 μm
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Figure 3. Oncogenic characteristics in gastric mucosa of Smad3−/− mice
(A) Ki-67 expression throughout the metaplastic fundic glands, including cysticly dilated
glands invading into submucosa as well as gastric epithelial glands within the muscle of the
gastric wall. (B) Higher magnification of A. (C) Higher magnification of A. Some regions of
gastric epithelial cells within the muscle of gastric wall showed no expression of Ki-67. (D)
E-cadherin expression in metaplastic and invasive region. Note the cytosolic E-cadherin in
papillary gland cells within the invading submucosal gland (Figure 3B). Right panel: Higher
magnification. Brown: E-cadherin, Red: TFF2/SP. (E) Activated form of STAT3,
phosphoSTAT3, expression in gastric epithelial cells just above invading gland within the
muscle layer. Right panel: Higher magnification. Bar size, 50μm
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Figure 4. STAT3 and phosphoSTAT3 expression in Smad3 knockdown gastric cancer cell lines
Immunoblot analyses of the Smad3 protein and phospho-STAT3 levels in AGS and MKN28
cells using beta-actin as a loading control. The shRNA-mediated knockdown of Smad3
increased the phosphorylated form of STAT3 in both AGS and MKN28 gastric cancer cells.
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Figure 5. DCLK1 expression in normal wild type gastric mucosa and Smad3−/− mouse tumor
(A) DCLK1 expression in normal wild type mouse. Note the cells present in the first fundic
gland in the transition zone junction between the forestomach and the glandular epithelium
(Junction), Fundus and Antrum. Each right hand panel: Higher magnification of DCLK1
positive cells (B–E) DCLK1 expression in Smad3−/− mouse tumor. (B) DCLK1 staining
cells in the transition zone junction between the forestomach and the glandular epithelium.
(C) The middle of developed tumor in a section including the area of initiated invasion.
Right panel: Higher magnification of tumor region. (D) Invading epithelial gland within
muscle wall. Bottom panel: Higher magnification. Note DCLK1-positive cells with
projections that contact the cystic gland lumen. (E) Antrum of Smad3−/− mouse tumor.
There was no change in DCLK1-expressing cells. (F) The quantitation of DCLK1-positive
cells in wild type and Smad3−/− mice. (*p<0.01 compared with wild type mice). Bar size,
50μm
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Figure 6. DCLK1-positive cells do not express biomarkers associated with differentiated lineages
in Smad3−/− mice tumor
(A) Double immunostaining for DCLK1 and TFF2/SP. DCLK1-positive cells did not co-
localized with TFF2/SP in any other region of tumor including invading epithelial gland
within muscle wall (D). (B) Double immunostaining for DCLK1 and chromogranin A.
DCLK1-positive cells did not co-localized with chromogranin A. (C) Double
immunostaining for DCLK1 and Ki-67. DCLK1-positive cells did not co-localized with
Ki-67. Right hand panel: higher magnification. (D) Higher magnification of A. (E) Higher
magnification of D. Bar size, 50μm
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Figure 7. DCLK1-positive cells express tuft cell markers
(A) Double immunostaining for DCLK1 (red) and acetylated-α-tubulin (green). Upper
panel: transition zone at the junction of the forestomach and the glandular epithelium (F/G)
in normal wild type mouse, Dashed line; gastric lumen boundary.; Bottom panel: Smad3−/−
mouse tumor, Dashed line: muscle layer boundary. (B) Higher magnification of A. (C)
Double immunostaining for DCLK1 (red) and α-gustducin (green). Upper panel: transition
zone at the junction of the forestomach and the glandular epithelium (F/G) in a normal wild
type mouse, Dashed line: gastric lumen boundary. Bottom panel: Smad3−/− mouse tumor.
Bar size, 50 μm.
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